NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
April 15, 2025
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home
April 9, 2025
NeuroNOS Announces Groundbreaking Research Publication by its CSO Demonstrating Mechanism of Action in Alzheimer’s Disease and Reinforcing Platform’s Strength Across Neurological Disorders
April 1, 2025
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
March 31, 2025
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy
March 24, 2025
Beyond Air Announces Agreements Expanding Global Distribution of LungFit® PH
March 11, 2025
Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences
March 6, 2025
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
February 10, 2025
Beyond Air® Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
February 5, 2025
Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast
January 27, 2025

Sign up for updates from Beyond Air, Inc.

Unsubscribe from all email communications.

Unsubscribe from all email communications. Unsubscribe